COXSACKIE A24 VIRUS MONOCLONAL ANTIBODY

COXSACKIE A24 VIRUS MONOCLONAL ANTIBODY is an FDA 510(k)-cleared medical device (K936089) manufactured by Chemicon Intl., Inc.. This device is classified under the Microbiology specialty. FDA Device Class I (General Controls) — lowest risk category. FDA clearance granted on September 7, 1995. Regulation: 8.